Emotion processing in schizophrenia and its relation to μ-opioid receptor availability. [PDF]
Shatalina E +6 more
europepmc +1 more source
Abstract Intranasal diamorphine (IND), approved for managing breakthrough pain in the UK, has been identified as an acceptable alternative offering effective, expedient, and less traumatic analgesia for children. However, the current dose regimen in pediatric populations relies on clinical expertise while the pharmacokinetics properties are poorly ...
Lianjin Cai +6 more
wiley +1 more source
Casomorphine-10 (CM-10) Peptide Orchestrates Circadian and Neurodevelopmental Gene Clusters via δ-Opioid Receptor Signaling: Insights from Transcriptome Analysis with δ-Opioid Receptor-Expressing HEK293 Cells. [PDF]
Fukunaga M +3 more
europepmc +1 more source
ABSTRACT Enhanced Recovery After Surgery (ERAS) protocols for cesarean deliveries (CDs) utilize multimodal pain management strategies that often include gabapentin. While gabapentin is excreted in breast milk, its pharmacokinetics in immediately postpartum lactating women are not known. This observational pharmacokinetic study (NCT05099484) enrolled 21
Rebecca Silvola +9 more
wiley +1 more source
μ-Opioid Receptor Dynamics in the Parameningeal Tissue During Migraine Attacks. [PDF]
Kim DJ +6 more
europepmc +1 more source
Evaluation of Potential Hormonal Activities of Ashwagandha (Withania somnifera)
ABSTRACT Ashwagandha is a widely used herb in traditional medicine systems, particularly Ayurveda. Despite its extensive tradition, growing concerns regarding its potential endocrinological effects have prompted scientific scrutiny. This review systematically evaluates the current preclinical, clinical, and case study evidence concerning AS's effects ...
Günter Vollmer, Thomas Brendler
wiley +1 more source
Structural Determinants of Buprenorphine Partial Agonism at the μ-Opioid Receptor. [PDF]
Gomes AAS, Giraldo J.
europepmc +1 more source
Structural and dynamic insights into the biased signaling mechanism of the human kappa opioid receptor. [PDF]
Suno-Ikeda C +22 more
europepmc +1 more source
Aberrant type 2 dopamine and mu-opioid receptor availability in autism spectrum disorder. [PDF]
Noppari T +12 more
europepmc +1 more source

